Messages in brief
Instructions for the correct use of auto-injectors with the active ingredient adrenaline (epinephrine) for emergency treatment
Safety warnings
|
messages in brief
|
25/09/2014
Auto-injectors containing adrenaline are used for emergency treatment of anaphylactic shock or allergic reaction (e.g. to insect stings or bites, food…
Current information on manipulated drugs
Safety warnings
|
messages in brief
|
17/09/2014
Situation EU: In addition to individual cases of manipulated, parallel distributed Italian Herceptin, manipulated, parallel distributed MabThera of…
"Operation Vigorali": Europe-wide trafficking of counterfeit medicines solved
messages in brief
|
01/09/2014
The Federal Criminal Police Office, in cooperation with AGES, today struck a decisive blow against an international drug counterfeiting ring.
"Operation Vigorali": Europe-wide trafficking of counterfeit medicines solved
Read more
"Morning-after pill" remains appropriate emergency contraception in every weight class
messages in brief
|
28/07/2014
Reassessment completed with regard to higher body weight or BMI.
"Morning-after pill" remains appropriate emergency contraception in every weight class
Read more
EU Commission introduces logo to ensure consumer safety in online pharmacies
messages in brief
|
24/06/2014
Implementing regulation adopted for a common logo for online pharmacies to verify authenticity under the Falsified Medicines Directive.
EU Commission introduces logo to ensure consumer safety in online pharmacies
Read more
Drug theft: more products affected (additionally Avastin and MabThera)
Safety warnings
|
messages in brief
|
04/06/2014
Update on stolen vials of Herceptin and other products, newly affected: Avastin and MabThera
Drug theft: more products affected (additionally Avastin and MabThera)
Read more
Information regarding the unapproved drug "Reniale
Safety warnings
|
messages in brief
|
30/05/2014
The BASG dissociates itself from statements on the homepage of the manufacturer of the unapproved drug "Reniale
Information regarding the unapproved drug "Reniale
Read more
Revocation of marketing authorizations for metoclopramide 4 mg/ml drops, including update 10/27/2014.
Safety warnings
|
messages in brief
|
30/04/2014
European Commission orders withdrawal of approval for metoclopramide-containing medicines in drop form with a concentration higher than 1 mg/ml.
Revocation of marketing authorizations for metoclopramide 4 mg/ml drops, including update 10/27/2014.
Read more
Questions and answers about counterfeit drugs Herceptin, Alimta and Remicade
Safety warnings
|
messages in brief
|
25/04/2014
Questions and answers about the stolen vials of Herceptin and other affected products
Questions and answers about counterfeit drugs Herceptin, Alimta and Remicade
Read more
New information on Herceptin theft
Safety warnings
|
messages in brief
|
17/04/2014
Situation Austria: currently only parallel marketed Italian Herceptin and Alimta are affected (as of 18.4.2014).
The drug Herceptin is approved…
